BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 18981443)

  • 21. The emperor has no clothes: dementia treatment on the eve of the aging era.
    Royall DR
    J Am Geriatr Soc; 2005 Jan; 53(1):163-4. PubMed ID: 15667396
    [No Abstract]   [Full Text] [Related]  

  • 22. Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial.
    Tariot PN; Farlow MR; Grossberg GT; Graham SM; McDonald S; Gergel I;
    JAMA; 2004 Jan; 291(3):317-24. PubMed ID: 14734594
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Guidelines for dementia or Parkinson's disease with depression or anxiety: a systematic review.
    Goodarzi Z; Mele B; Guo S; Hanson H; Jette N; Patten S; Pringsheim T; Holroyd-Leduc J
    BMC Neurol; 2016 Nov; 16(1):244. PubMed ID: 27887589
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of dementia: anything new?
    Machado JC; Caramelli P
    Curr Opin Psychiatry; 2006 Nov; 19(6):575-80. PubMed ID: 17012934
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cholinesterase inhibitors and memantine for symptomatic treatment of dementia.
    Rodda J; Carter J
    BMJ; 2012 May; 344():e2986. PubMed ID: 22550350
    [No Abstract]   [Full Text] [Related]  

  • 26. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systematic appraisal of dementia guidelines for the management of behavioural and psychological symptoms.
    Azermai M; Petrovic M; Elseviers MM; Bourgeois J; Van Bortel LM; Vander Stichele RH
    Ageing Res Rev; 2012 Jan; 11(1):78-86. PubMed ID: 21856452
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacological treatment of Alzheimer disease.
    Massoud F; Léger GC
    Can J Psychiatry; 2011 Oct; 56(10):579-88. PubMed ID: 22014690
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Assessment of dementia and use of anti-dementia drugs in nursing homes].
    Engedal K
    Tidsskr Nor Laegeforen; 2005 May; 125(9):1188-90. PubMed ID: 15880157
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-pharmacologic treatment of insomnia in persons with dementia.
    Shub D; Darvishi R; Kunik ME
    Geriatrics; 2009 Feb; 64(2):22-6. PubMed ID: 19256583
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effectiveness of adding memantine to an Alzheimer dementia treatment regimen which already includes stable donepezil therapy: a critically appraised topic.
    Riordan KC; Hoffman Snyder CR; Wellik KE; Caselli RJ; Wingerchuk DM; Demaerschalk BM
    Neurologist; 2011 Mar; 17(2):121-3. PubMed ID: 21364371
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectiveness of interventions that assist caregivers to support people with dementia living in the community: a systematic review.
    Parker D; Mills S; Abbey J
    Int J Evid Based Healthc; 2008 Jun; 6(2):137-72. PubMed ID: 21631819
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Guidelines for the management of cognitive and behavioral problems in dementia.
    Sadowsky CH; Galvin JE
    J Am Board Fam Med; 2012; 25(3):350-66. PubMed ID: 22570399
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Consensus statement "Dementia 2010" of the Austrian Alzheimer Society].
    Schmidt R; Marksteiner M; Dal-Bianco P; Ransmayr G; Bancher C; Benke T; Wancata J; Fischer P; Leblhuber CF; Psota G; Ackerl M; Alf C; Berek K; Croy A; Delazer M; Fasching P; Frühwald T; Fruhwürth G; Fuchs-Nieder B; Gatterer G; Grossmann J; Hinterhuber H; Iglseder B; Imarhiagbe D; Jagsch C; Jellinger K; Kalousek M; Kapeller P; Ladurner G; Lampl C; Lechner A; Lingg A; Nakajima T; Rainer M; Reisecker F; Spatt J; Walch T; Uranüs M; Walter A
    Neuropsychiatr; 2010; 24(2):67-87. PubMed ID: 20605003
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost-utility analysis of memantine extended release added to cholinesterase inhibitors compared to cholinesterase inhibitor monotherapy for the treatment of moderate-to-severe dementia of the Alzheimer's type in the US.
    Saint-Laurent Thibault C; Özer Stillman I; Chen S; Getsios D; Proskorovsky I; Hernandez L; Dixit S
    J Med Econ; 2015; 18(11):930-43. PubMed ID: 26086535
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Antidementia drugs].
    Müller-Spahn F; Sollberger D; Wollmer MA
    Ther Umsch; 2009 Jun; 66(6):432-40. PubMed ID: 19496039
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The practice guideline 'Diagnosis and pharmaceutical treatment of dementia'].
    van Gool WA; Stam CJ; Steenhoek A; Hagemeijer A
    Ned Tijdschr Geneeskd; 2006 Apr; 150(15):839-43. PubMed ID: 16676513
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Benefits of combined cholinesterase inhibitor and memantine treatment in moderate-severe Alzheimer's disease.
    Gauthier S; Molinuevo JL
    Alzheimers Dement; 2013 May; 9(3):326-31. PubMed ID: 23110864
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacological treatment of dementia and mild cognitive impairment due to Alzheimer's disease.
    Popp J; Arlt S
    Curr Opin Psychiatry; 2011 Nov; 24(6):556-61. PubMed ID: 21934621
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Review of the effect of music interventions on symptoms of anxiety and depression in older adults with mild dementia.
    Petrovsky D; Cacchione PZ; George M
    Int Psychogeriatr; 2015 Oct; 27(10):1661-70. PubMed ID: 25921299
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.